MedPath

Study on the efficacy of octreotide acetate for cancer-related bowel obstructio

Not Applicable
Conditions
cancer-related bowel obstruction
Registration Number
JPRN-UMIN000000521
Lead Sponsor
niversity of Tsukuba
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients with cognitive dysfunction 2)Patients with esophageal obstruction 3)Patients with symptomatic brain metastases or meningeal dissemination 4)Patients undergoing anticancer treatment or radiotherapy within the last 2 weeks 5)Patients judged by the physician in charge to be unsuitable for this study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Amelioration of abdominal symptoms (subjective parameters)
Secondary Outcome Measures
NameTimeMethod
1)Reduction in the number of vomiting episodes and the volume of drainage from a gastric tube (Objective parameters) 2)Correlation between subjective and objective parameters 3)Differences in the efficacy of treatment with octreotide acetate among different cancer types or obstruction sites 4)Assessment of safety in octreotide acetate therapy
© Copyright 2025. All Rights Reserved by MedPath